Ignite Creation Date:
2025-12-25 @ 2:42 AM
Ignite Modification Date:
2026-01-08 @ 1:39 PM
Study NCT ID:
NCT02869633
Status:
COMPLETED
Last Update Posted:
2023-10-23
First Post:
2016-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
Sponsor:
Vanderbilt-Ingram Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-11
Start Date Type:
ACTUAL
Primary Completion Date:
2021-11-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-10
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-10
First Submit QC Date:
None
Study First Post Date:
2016-08-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2022-10-18
Results First Submit QC Date:
None
Results First Post Date:
2023-01-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-10-17
Last Update Post Date:
2023-10-23
Last Update Post Date Type:
ACTUAL